Abeona Therapeutics
(ABEO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,053 | -21,744 | -8,193 | -6,236 | -4,127 |
| Depreciation Amortization | 88 | 2,595 | 2,526 | 2,465 | 2,290 |
| Accounts receivable | 35 | -607 | -502 | 151 | 3 |
| Other Working Capital | -1,493 | 1,545 | 1,568 | 678 | 254 |
| Other Operating Activity | 9,034 | 13,368 | 1,358 | 452 | 289 |
| Operating Cash Flow | $-4,389 | $-4,843 | $-3,243 | $-2,490 | $-1,291 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 599 | N/A | 2,680 | 1,465 | 471 |
| PPE Investments | -22 | -5 | -18 | -18 | -15 |
| Net Acquisitions | -65 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 13 | 0 | 0 |
| Investing Cash Flow | $512 | $-5 | $2,675 | $1,447 | $456 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -64 | -1,327 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 35 | 35 | 19 | N/A |
| Other Financing Activity | 2,444 | 8,672 | 0 | 0 | 0 |
| Financing Cash Flow | $2,380 | $7,380 | $35 | $19 | $N/A |
| Beginning Cash Position | 2,583 | 4,389 | 1,194 | 1,194 | 1,194 |
| End Cash Position | 1,086 | 6,921 | 661 | 170 | 359 |
| Net Cash Flow | $-1,497 | $2,532 | $-533 | $-1,024 | $-835 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,389 | -4,843 | -3,243 | -2,490 | -1,291 |
| Capital Expenditure | -22 | -18 | -18 | -18 | -15 |
| Free Cash Flow | -4,411 | -4,861 | -3,261 | -2,508 | -1,306 |